J&J, Emergent Accuse Each Other Of Violating COVID-19 Vaccine Deal

Johnson & Johnson and Emergent BioSolutions are accusing each other of breaching their COVID-19 vaccine supply agreement.

In a formal notice, J&J said that Emergent had failed to supply the vaccine drug substance needed to meet its manufacturing obligations, prompting the former to issue a notice of termination. Conversely, in a securities filing, Emergent claimed that it has also sent a notice of material breach of the agreement to J&J for failing to comply with minimum order requirements and not providing the required forecasts necessary for its order.